Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
Partnered Content
PDF Library
RSS Feeds
Subscribe
Advertising
Report Store
UsernamePublicRestriction
Tags:
Legislation Clinical Trials Policy

Posting Preapproval Access Policies Could Help Prevent ‘Blame And Shame’ Under Right To Try

  • Analysis

Executive Summary

Many biopharmas have not publicly posted their policies for evaluating and responding to expanded access requests as required under the 21st Century Cures Act. Putting this information out will help set patient community expectations, but will not viewed by US FDA as off-label promotion, experts say at BIO annual meeting.

Table

View full table

Advertisement

Related Content

Pink Sheet
Expanded Access: US FDA Told To Increase Regulatory Clarity, Early Interactions With Sponsors
Pink Sheet
US FDA's Woodcock: Sponsors Have To Make Right-To-Try Decisions
Pink Sheet
Why The Right-To-Try Law Is Not Right For Some Biotech Companies
Pink Sheet
US FDA Right To Try Policy: For Now, Defer Questions To Sponsors, Bill Text
Pink Sheet
FDA's Compassionate Use Initiatives: Web Clearinghouse, Guidance Documents

Topics

Related Companies

Advertisement
Tags:
Legislation Clinical Trials Policy
UsernamePublicRestriction

Register

PS123280

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By